Kneat Announces Selection by Top Ten Biopharma as the Corporate Solution for Global Manufacturing and Provides an Update on its Recent Financing
Kneat Announces Selection by Top Ten Biopharma as the Corporate Solution for Global Manufacturing and Provides an Update on its Recent Financing News provided by Share this article LIMERICK, Ireland, May 7, 2021 /CNW/ - kneat.com, inc. (TSX-V: KSI) ("Kneat") announces it has signed a five-year corporate Master Services Agreement (MSA) with another top ten biopharma company, and provides an update on its recent financing. Top Ten Biopharma Selects Kneat as its Corporate Validation Platform for Global Manufacturing In December 2020, Kneat announced its SaaS platform was chosen by this rese...
Source: newswire.ca